SCHEMBL522409

SCHEMBL522409

CC(C)SCOCc1ccccc1[C]=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9166919 0.83
SCHEMBL522138 0.82 FFAR1 (0.31)
SCHEMBL7672866 0.76 L3MBTL1 (0.34)
SCHEMBL522410 0.75 LMNA (0.36)
SCHEMBL28016352 0.74 SMN1; SMN2 (0.38)
SCHEMBL7677777 0.72 FFAR1 (0.47)
SCHEMBL16097299 0.71 TSHR (0.56)
SCHEMBL5985113 0.69 GABRA1 (0.47)
SCHEMBL535892 0.67 GABRA1 (0.45)
SCHEMBL442437 0.67 ALDH1A1 (0.52)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 274 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7576119-B2 Supports for oligomer synthesis ISIS PHARMACEUTICALS, INC. (US) 2009-08-18 US claimed
US-20080021224-A1 SUPPORTS FOR OLIGOMER SYNTHESIS ISIS PHARMACEUTICALS, INC. (US) 2008-01-24 US claimed
US-7202264-B2 Supports such as glass and styrene polymers functionalized with tricyclic hetercyclic anhydrides and imides, used in the preparation of oligonucleotides ISIS PHARMACEUTICALS, INC. (US) 2007-04-10 US claimed
EP-1670810-A2 GAPPED OLIGOMERIC COMPOUNDS HAVING LINKED BICYCLI CSUGAR MOIETIES AT THE TERMINI Isis Pharmaceuticals, Inc. (US) 2006-06-21 EP claimed
US-20050208588-A1 Supports for oligomer synthesis ISIS PHARMACEUTICALS, INC. (US) 2005-09-22 US claimed
US-20050059066-A1 Gapped oligomeric compounds having linked bicyclic sugar moieties at the termini IONIS PHARMACEUTICALS, INC. 2005-03-17 US claimed
WO-2005023825-A2 GAPPED OLIGOMERIC COMPOUNDS HAVING LINKED BICYCLIC SUGAR MOIETIES AT THE TERMINI ISIS PHARMACEUTICALS, INC. (US) 2005-03-17 WO claimed
US-20050053981-A1 Gapped oligomeric compounds having linked bicyclic sugar moieties at the termini ISIS PHARMACEUTICALS, INC. 2005-03-10 US claimed
US-20040242897-A1 Universal support media for synthesis of oligomeric compounds ISIS PHARMACEUTICALS, INC. 2004-12-02 US claimed
US-20040142946-A1 Modified nucleosides and nucleotides and use thereof CHATTOPADHYAYA JYOTI (SE) 2004-07-22 US claimed
US-5721350-A Deuterated nucleosides CHATTOPADHYAYA JYOTI (SE) 1998-02-24 US claimed
JP-H09510206-A 1997-10-14 JP claimed
US-5623068-A Synthesis of DNA using substituted phenylacetyl-protected nucleotides BECKMAN INSTRUMENTS, INC. (US) 1997-04-22 US claimed
EP-0749436-A1 COMPOSITIONS AND METHODS FOR USE IN THE SYNTHESIS OF OLIGONUCLEOTIDES BECKMAN INSTRUMENTS, INC. (US) 1996-12-27 EP claimed
US-5574146-A Oligonucleotide synthesis with substituted aryl carboxylic acids as activators BECKMAN INSTRUMENTS, INC. (US) 1996-11-12 US claimed
EP-0725787-A1 ACTIVATED NUCLEOSIDE PHOSPHORAMIDITES AND METHODS FOR THE PREPARATION AND USE THEREOF BECKMAN INSTRUMENTS, INC. (US) 1996-08-14 EP claimed
WO-1996006853-A1 ACTIVATED NUCLEOSIDE PHOSPHORAMIDITES AND METHODS FOR THE PREPARATION AND USE THEREOF BECKMAN INSTRUMENTS, INC. (US) 1996-03-07 WO claimed
WO-1995024413-A1 COMPOSITIONS AND METHODS FOR USE IN THE SYNTHESIS OF OLIGONUCLEOTIDES BECKMAN INSTRUMENTS, INC. (US) 1995-09-14 WO claimed
EP-0648220-A1 DEUTERATED NUCLEOSIDES CHATTOPADHYAYA, Jyoti (SE) 1995-04-19 EP claimed
WO-1993025566-A1 DEUTERATED NUCLEOSIDES CHATTOPADHYAYA JYOTI (SE) 1993-12-23 WO claimed